Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Mangogna

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Nanomedicine (London, England)|January 15, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinomaMonica Mossenta, Monica Argenziano, Sara Capolla, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping ReviewLorenzo Lippi, Alessandro de Sire, Vittorio Aprile, et al.
Frontiers in Immunology|June 12, 2023
Genetic bases of C7 deficiency: systematic review and report of a novel deletion determining functional hemizygosityAndrea Balduit, Anna Monica Bianco, Alessandro Mangogna, et al.
Frontiers in Immunology|December 7, 2017
Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor GrowthChiara Agostinis, Romana Vidergar, Beatrice Belmonte, et al.
Frontiers in Immunology|February 5, 2021
Prognostic Value of Complement Properdin in CancerAlessandro Mangogna, Praveen M Varghese, Chiara Agostinis, et al.
Nanomedicine (London, England)|December 2, 2024
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cellsFederica Di Cintio, Monica Argenziano, Anna Scomparin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 6, 2020
Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo modelsChiara Agostinis, Fleur Bossi, Alessandro Mangogna, et al.
International Journal of Molecular Sciences|April 3, 2019
Transcriptomics and Immunological Analyses Reveal a Pro-Angiogenic and Anti-Inflammatory Phenotype for Decidual Endothelial CellsChiara Agostinis, Elisa Masat, Fleur Bossi, et al.
Cancers|September 29, 2020
Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined GroupsGiovanni Centonze, Davide Biganzoli, Natalie Prinzi, et al.
Critical Reviews in Oncology/Hematology|June 7, 2026
Advances in early-stage lung cancer patients: from preanalytics to molecular analysisFrancesco Pepe, Valerio Gristina, Tancredi Didier Bazan Russo, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Nanomedicine (London, England)|January 15, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinomaMonica Mossenta, Monica Argenziano, Sara Capolla, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping ReviewLorenzo Lippi, Alessandro de Sire, Vittorio Aprile, et al.
Frontiers in Immunology|June 12, 2023
Genetic bases of C7 deficiency: systematic review and report of a novel deletion determining functional hemizygosityAndrea Balduit, Anna Monica Bianco, Alessandro Mangogna, et al.
Frontiers in Immunology|December 7, 2017
Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor GrowthChiara Agostinis, Romana Vidergar, Beatrice Belmonte, et al.
Frontiers in Immunology|February 5, 2021
Prognostic Value of Complement Properdin in CancerAlessandro Mangogna, Praveen M Varghese, Chiara Agostinis, et al.
Nanomedicine (London, England)|December 2, 2024
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cellsFederica Di Cintio, Monica Argenziano, Anna Scomparin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 6, 2020
Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo modelsChiara Agostinis, Fleur Bossi, Alessandro Mangogna, et al.
International Journal of Molecular Sciences|April 3, 2019
Transcriptomics and Immunological Analyses Reveal a Pro-Angiogenic and Anti-Inflammatory Phenotype for Decidual Endothelial CellsChiara Agostinis, Elisa Masat, Fleur Bossi, et al.
Cancers|September 29, 2020
Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined GroupsGiovanni Centonze, Davide Biganzoli, Natalie Prinzi, et al.
Critical Reviews in Oncology/Hematology|June 7, 2026
Advances in early-stage lung cancer patients: from preanalytics to molecular analysisFrancesco Pepe, Valerio Gristina, Tancredi Didier Bazan Russo, et al.
Pageof 10